Achieving the WHO hepatitis C elimination goals: mapping existing gaps in care, determining the economic burden, and identifying areas of investment along the care-cascade that optimize health outcomes among immigrants living with hepatitis C in Canada
Achieving the WHO hepatitis C elimination goals: mapping existing gaps in care, determining the economic burden, and identifying areas of investment along the care-cascade that optimize health outcomes among immigrants living with hepatitis C in Canada
实现世界卫生组织消除丙型肝炎的目标：绘制护理方面的现有差距，确定经济负担，并确定护理级联中的投资领域，以优化加拿大丙型肝炎移民的健康结果
批准号：
413215
负责人：
Erman Aysegul
金额：
$9.83万
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-10-01 至 2022-10-01
中文摘要
翻译
2013年推出了极其有效的直接作用抗病毒药物(DAA)，使丙型肝炎病毒(HCV)的治疗发生了革命性的变化。这些药物为消除丙型肝炎病毒作为公共卫生问题提供了令人兴奋的机会。为此，世界卫生组织已经
英文摘要
Hepatitis C virus (HCV) treatment has been revolutionized by the introduction of extremely effective direct-acting antivirals (DAAs) in 2013. These drugs offer exciting opportunities to eliminate HCV as a public health concern. To this end, the WHO has se
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
